ALLMedicine™ Anaplastic Ependymoma Center
Research & Reviews 75 results
https://doi.org/10.1007/s00381-023-05846-y
Child's Nervous System : ChNS : Official Journal of the I... Mui OOT, Murray DB et. al.
Jan 21st, 2023 - The primary objective of neurosurgical management of malignant gliomas is maximal safe resection of the tumour. One of the main obstacles in achieving this is the ability to accurately discriminate between tumour edges and the surrounding healthy ...
https://clinicaltrials.gov/ct2/show/NCT03434262
Dec 7th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...
https://doi.org/10.1017/cjn.2022.310
The Canadian Journal of Neurological Sciences. Le Journal... Tarzi C, Alnemari AM et. al.
Oct 28th, 2022 - Unusual Case of Multilevel Spinal Anaplastic Ependymoma: Case Report.|2022|Tarzi C,Alnemari AM,Woulfe J,Drake B,|
https://doi.org/10.21873/anticanres.15878
Anticancer Research; DE Laclos XC, Frappaz D et. al.
Jul 28th, 2022 - Anaplastic ependymoma is a rare cancer of the central nervous system. The treatment includes optimal resection with focal radiotherapy. Some case reports or retrospective studies have suggested efficacy of regimens containing platinum or bevacizum...
https://clinicaltrials.gov/ct2/show/NCT03727841
Jul 27th, 2022 - Background: Ependymomas are rare primary brain tumors arising from radial glial stem cells. They comprise 5.2% of all pediatric primary brain tumors and 1.9% of all adult primary brain tumors. The standard therapy for newly diagnosed ependymoma is...
Clinicaltrials.gov 5 results
https://clinicaltrials.gov/ct2/show/NCT03434262
Dec 7th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...
https://clinicaltrials.gov/ct2/show/NCT03727841
Jul 27th, 2022 - Background: Ependymomas are rare primary brain tumors arising from radial glial stem cells. They comprise 5.2% of all pediatric primary brain tumors and 1.9% of all adult primary brain tumors. The standard therapy for newly diagnosed ependymoma is...
https://clinicaltrials.gov/ct2/show/NCT01295944
May 17th, 2022 - Background: Ependymomas are glial based tumors arising from the ependymal lining of the ventricular system and central canal of the spinal cord These tumors affect both adults and children and represent approximately 1.2%-7.8% of all intracranial ...
https://clinicaltrials.gov/ct2/show/NCT00027846
Aug 7th, 2019 - OBJECTIVES: Determine the local control and pattern of failure in children with completely resected, differentiated, supratentorial localized ependymoma after initial surgical resection alone. Determine the rate of complete resection with second s...
https://clinicaltrials.gov/ct2/show/NCT00002463
Feb 18th, 2013 - OBJECTIVES: I. Determine the efficacy of high-dose methotrexate (HMTX) in combination with mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) in infants or young children with primitive neuroectodermal tumors (PNET) (including medul...
News 2 results
https://www.onclive.com/view/oncolytic-virus-shows-early-promise-in-glioma
Dec 20th, 2020 - Frederick F. Lang, MD The oncolytic virus Delta-24-RGD can infect, replicate, and kill glioma cells in patients, according to phase I research presented at the 2014 Society for Neuro-Oncology (SNO) Annual Meeting in Miami. Delta-24-RGD is a nove...
https://www.onclive.com/view/expert-discusses-molecular-analysis-and-treatment-options-in-pediatric-ependymoma
Dec 4th, 2020 - Santhosh A. Upadhyaya, MD Among pediatric patients with ependymoma, investigators found no difference in 4-year survival by molecular subgroups, according to results from the SJYC07 trial presented at the 2018 ASCO Annual Meeting. Among patients...
